Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Cancer Cell. 2012 Aug 14;22(2):209-21. doi: 10.1016/j.ccr.2012.06.007.
The oncogenic transcription factor TAL1/SCL is aberrantly expressed in over 40% of cases of human T cell acute lymphoblastic leukemia (T-ALL), emphasizing its importance in the molecular pathogenesis of T-ALL. Here we identify the core transcriptional regulatory circuit controlled by TAL1 and its regulatory partners HEB, E2A, LMO1/2, GATA3, and RUNX1. We show that TAL1 forms a positive interconnected autoregulatory loop with GATA3 and RUNX1 and that the TAL1 complex directly activates the MYB oncogene, forming a positive feed-forward regulatory loop that reinforces and stabilizes the TAL1-regulated oncogenic program. One of the critical downstream targets in this circuitry is the TRIB2 gene, which is oppositely regulated by TAL1 and E2A/HEB and is essential for the survival of T-ALL cells.
致癌转录因子 TAL1/SCL 在超过 40%的人类 T 细胞急性淋巴细胞白血病(T-ALL)病例中异常表达,强调了其在 T-ALL 分子发病机制中的重要性。在这里,我们确定了由 TAL1 及其调节伙伴 HEB、E2A、LMO1/2、GATA3 和 RUNX1 控制的核心转录调节回路。我们表明,TAL1 与 GATA3 和 RUNX1 形成正相互连接的自调节环,并且 TAL1 复合物直接激活 MYB 癌基因,形成正反馈调节环,增强和稳定 TAL1 调节的致癌程序。该电路中的一个关键下游靶标是 TRIB2 基因,它受 TAL1 和 E2A/HEB 的相反调节,对 T-ALL 细胞的存活至关重要。